Abstract
The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 229-236 |
| Number of pages | 8 |
| Journal | Seminars in Thoracic and Cardiovascular Surgery |
| Volume | 21 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2009 |
Fingerprint
Keywords
- coronary surgery
- hybrid revascularization
- minimally invasive
- percutaneous coronary intervention
- robotics
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Surgery
- Pulmonary and Respiratory Medicine
Cite this
Current State of Integrated "Hybrid" Coronary Revascularization. / DeRose, Joseph.
In: Seminars in Thoracic and Cardiovascular Surgery, Vol. 21, No. 3, 09.2009, p. 229-236.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Current State of Integrated "Hybrid" Coronary Revascularization
AU - DeRose, Joseph
PY - 2009/9
Y1 - 2009/9
N2 - The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.
AB - The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.
KW - coronary surgery
KW - hybrid revascularization
KW - minimally invasive
KW - percutaneous coronary intervention
KW - robotics
UR - http://www.scopus.com/inward/record.url?scp=70449707640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449707640&partnerID=8YFLogxK
U2 - 10.1053/j.semtcvs.2009.08.004
DO - 10.1053/j.semtcvs.2009.08.004
M3 - Article
VL - 21
SP - 229
EP - 236
JO - Seminars in Thoracic and Cardiovascular Surgery
JF - Seminars in Thoracic and Cardiovascular Surgery
SN - 1043-0679
IS - 3
ER -